ConductScience.org, home

Library / Genes

FANCB: FA complementation group B

1 protein, 22 patents, 0 drugs, 0 trials, 3,862 NIH grants and 7,611 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolFANCBHGNC
NameFA complementation group BHGNC
NCBI Gene ID2187NCBI Gene
HGNC IDHGNC:3583HGNC
EnsemblENSG00000181544NCBI Gene
AliasesFA2, FAAP90, FAAP95, FAB, FACB, FLJ34064NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q8NB91Fanconi anemia group B protein8596Ensembl, GeneID, HGNCUniProt

Patents 22

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1445835Q8NB91Espacenet
JP 2026004568 A2026-01-1445836Q8NB91Espacenet
US 11976334 B22024-05-07146Q8NB91Espacenet
US 11446398 B22022-09-2030653Q8NB91Espacenet
US 11446398 B22022-09-2030654Q8NB91Espacenet
JP 2022524081 A2022-04-27133624Q8NB91Espacenet
JP 2022524081 A2022-04-27133625Q8NB91Espacenet
US 11078247 B22021-08-033883Q8NB91Espacenet
JP 2020508335 A2020-03-19146Q8NB91Espacenet
KR 1020190120204 A2019-10-23146Q8NB91Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3862

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
ZIAAI005022Antibody Neutralization Mechanisms372,025NIH's project files
P30CA008748Cancer Center Support Grant352,025NIH's project files
P30CA016672Cancer Center Support Grant332,025NIH's project files
UM1AI144462Consortium for HIV/AIDS Vaccine Development322,025NIH's project files
P01AI100148Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies262,025NIH's project files
ZICAI005111Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation192,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)182,025NIH's project files
P30GM124169ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE)162,025NIH's project files
ZICAI005112Computational Tools for Structural Analysis162,025NIH's project files
P30GM124165NE-CAT: A Resource for Advanced Macromolecular Crystallography152,025NIH's project files

Papers 7611

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42823572PubTator, text miningPubMed
42819945PubTator, text miningPubMed
42818533PubTator, text miningPubMed
42799830PubTator, text miningPubMed
42711200PubTator, text miningPubMed
42709784PubTator, text miningPubMed
42686226PubTator, text miningPubMed
42677561PubTator, text miningPubMed
42657177PubTator, text miningPubMed
42638115PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license